Orosomucoid was evaluated by laser-nephelometry in 1790 sera collected from 1170 newborns. Within-run precision (CV) was 2.1 to 4.2%, between-run 2.9 to 5.2%. Results correlated well with radial immunodiffusion (r = 0.989). Results can be obtained within 1 h. Orosomucoid concentrations in serum at birth range from 130 to 200 mg/L and are influenced by gestational age during the first two days of postnatal life. Thereafter, the values increase very rapidly in the first week of life, concentrations being the same as in adults by about 10 months. In 66 of 78 cases of severe bacterial infections, orosomucoid concentrations were above normal. Evidently, serum orosomucoid constitutes an useful index in diagnosis and monitoring of bacterial infections in the neonatal period.
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Orosomucoid (a1-acid glycoprotein) is a glycoprotein of low molecular mass (1), one of the acute-phase reactants. As is true of these reactants (which include C-reactive protein, haptoglobin, and a1-antitrypsin), the circulating orosomucoid increases in the presence of inflammation and other related disease states, including cancer, pneumonia, or severe surgical stress.
Serum orosomucoid concentrations in the neonatal period have received little attention. In 1973, Gotoh et al. (2) measured orosomucoid by radial immunodiffusion (RID), and reported increased values in newborns with bacterial infections, We confirmed these results (3, 4) . However, the reference intervals have not been precisely evaluated, especially in premature infants. The present study was carried out to evaluate the variation of serum orosomucoid concentrations as a function of gestational and postnatal age in normal and sickneonates.
Because the RID method for orosomucoid determination requires at least 24 to 48 h, we developed a quicker method, laser nephelometry, for its measurement. Our data suggest that orosomucoid measurement by laser nephelometry constitutes a quick, precise, and useful tool for detection and followup of bacterial infections in newborns.
Materials and Methods

Blood Samples
We collected 1790 blood samples from 1170 infants, which were classified into three groups according to their clinical status.
Group I: Control group. We analyzed 411 sera from 352 control pre-and full-term infants and children for orosomu-coid. Of these 352 infants, 55 had sera sampled more than once. Although some of these control infants or children were hospitalized, it was for social rather than medical reasons. We confirmed the absence of infection by clinical, bacteriological, and virological examination of each infant. Specimens from this group included 323 sera from 264 newborns (167 pre-and 97 full-term infants), whose ages ranged from one to 32 days, and 88 sera from 88 infants and children from one month to nine years of age.
Group II: Infected
neonates. Subgroup 11-1, bacterial infections: We collected 477 sera from 148 neonates (51 pre-term and 97 full-term infants) with clinical and biological infections, as diagnosed by positive culture from the blood of 58 infants (274 sera), from the cerebrospinal fluid of 10 infants (34 sera), from the brain abscess of one infant (8 sera), from the pentoneum of nine infants (26 sera), from the stools of 22 infants (37 sera), from the urines (more than 10 organismsfL) of seven infants (15 sera), and from the skin of 27 infants with severe cutaneous infections (60 sera). Infection was also diagnosed in 14 additional infants (23 sera), for which the same organism was detected in at least three of these different areas (5 
Methods
We collected 500-tL samples of blood in a polystyrene microtube without anticoagulant, by heel prick (or by venous puncture, in the case of older children), and removed the serum after centnifugation.
For laser nephelometry we used the Behning Laser Nephelometer module 1 (Behningwerke, D-3550 Marburg/Lahn, F.R.G.). Samples, standards, and antisera were diluted with sterile isotonic saline solution and 100 1zL of 101-fold diluted sample were mixed in a microcuvette with 200 sL of a fivefold diluted anti-orosomucoid antiserum (LN serum anti-orosomucoid SAW; Behringwerke).
The cuvettes were shaken briefly and allowed to stand for 1 h at room temperature, and the light scattered by the resulting antigen-antibody complexes was measured (in volts) with the nephelometer. A 1gM concentration was evaluated by lasernephelometry with an anti-IgM antiserum (OSAT; Behringwerke), with the same procedure as outlined for orosomucoid.
Fibrinogen was estimated according to Von Clauss (6). Statistical methods used were the Student's t -test and the nonparametnic Mann/Whitney U-test.
Methodological Aspects
Calibration curve and analytical range: An example of a calibration curve is shown in Figure 1 . This curve corresponds to a third-order polynomial; thus, unknown orosomucoid concentrations in sera can, if desired, be determined with an appropriate calculator. The analytical range is wide: 120 to 3900 mgfL for a 101-fold diluted serum.
Within-run precision, between-run precision: These data are summarized in Table 1 . The coefficients of variation were always <6%.
Correlation of laser nephelometry with radial immunodiffusion:
Orosomucoid in 90 sera was measured both by laser nephelometry (y) and RID (x). The correlation was excellent (r = 0.989) and the least-squares regression equation is y = x -0.013.
Clinical Aspects
Reference intervals were established according to gestational and postnatal age. Control infants from one to 32 days of age were classified into three groups according to gestational age: two groups for pre-term infants (26-32 weeks, inclusive, and 33-37 weeks, inclusive) and one group for full-term infants (38-41 weeks, inclusive).
The values do not follow a gaussian distribution (Figure 2 ), some onosomucoid concentrations being too high. Nevertheless, the mean + 2SD can be considered in practice as the upper limit of the reference interval for serum orosomucoid. Figure 3 shows the change in the mean ±1 SEM (standard error of the mean) in orosomucoid concentration with postnatal age (1-32 days) in pre-term and full-term infants. For all groups, serum orosomucoid values at birth are much lower than for adults. In full-term infants, orosomucoid shows a rapid postnatal increase, from 180 mg/L at birth to 520 mgfL at five or six days, and the difference is highly significant (p <10); thereafter the value remains constant for up to one month. In pre-term infants (26-32 and 33-37 weeks gestation, inclusive) the increase is more progressive between the first 12  515  243  70  1000   6  580  250  102  1080  25  820  200  40  1220  25  940  215  43  1370   14  840  177  47  1200  6  880  208  85  1300 and the second day of postnatal life; thereafter it parallels the course for full-term infants. Prematurity influences orosomucoid concentrations. Measured on the same postnatal day, mean concentrations at days 1 and 2 were significantly (p <0.05) lower in the 26-32 weeks group than in full-term infants. The difference is also significant between the 33-37 weeks of gestation and full-term groups at day 2, but not at day 1, owing to the more rapid increase of orosomucoid at day 2 in full-term infants than in pre-term 33-37 week infants. From day 3 the influence of gestational age on orosomucoid values is not significant. Consequently, we made no distinction between pre-term and full-term infants from one month to nine years of age (Table  2) . By 10 months, orosomucoid values are the same as in adults.
Orosomucoid in Infected Infants
In the following studies, the concentrations of orosomucoid in a particular infant were analyzed and compared with the reference values for normal infants of the same gestational and postnatal age. Bacterial infections: Figure 4 shows our results for infants with verified bacterial septicemia, meningitis, and peritonitis. Of 78 patients, 66 (44/52 for full-term and 22/26 for pre-term infants) had increased (i.e., >2 SD from the mean) orosomucoid concentrations at the time of the infection; the range was 80-3300 mg/L.
Of the 11 cases of meningitis (a case of brain abscess included), 10 had supranormal orosomucoid concentrations; the one case with normal values was an infection due to Proteus mirabilis.
One case of peritonitis, of the nine cases studied, had a very low value (80 mg/L), and the infant died on the eighth postnatal day. Of the 10 Overall in this group, of the 148 infected infants 118(80%) had high serum orosomucoid values. Figure 5 illustrates the variations of serum orosomucoid in eight cases of septicemia and in seven cases of meningitis in relation to the time since presumed onset of the infection.
These examples show that the increase of serum orosomucoid was very rapid after the beginning of the infection; nevertheless, in three cases of septicemia the initial value for orosomucoid was within the normal range, but an increase oc- curred subsequently. For uncomplicated cases of septicemia and under antibiotherapy the maximum orosomucoid concentrations were observed from three to six days since onset of infection, and the normalization of serum concentration of orosomucoid occurred after about seven to ten days since onset. This normalization could take up to three weeks for complicated cases. In our experience, the peak and normalization of orosomucoid during meningitis appeared a little later than during septicemia. In 11 cases the normalization was parallel to clinical recovery. In the four other cases studied, two infants died with high orosomucoid concentrations; for the other two, determinations
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were not made until complete recovery.
Orosornucoid in viral and parasitological infections: Concentrations
of serum orosomucoid in viral and parasitological infections are presented in Figure 6 . Increased values were observed in 16 of the 30 cases studied (53%), ranging from 180 to 2960 mg/L. The most increased values were observed in cytomegalovirus infections.
Orosomucoid in Sick Neonates without Infections
In seven of the 51 infants (14%) with respiratory distress syndrome and in 43 of the 137 asphyxiated neonates (31%), orosomucoid concentrations were increased. Serum orosomucoid concentrations were increased in 17 newborn infants in the group of 86 small-for-date infants (20%) and in 56 neonates in the group of 186 infants with congenital malformations, jaundice, or digestive syndromes
In eight of 10 cases (80%) of inflammatory diseases, high orosomucoid values were observed, but this increase was expected because orosomucoid belongs to the acute-phase proteins, which increase in concentration in inflammations.
Of the 170 infants with suspected infections only 42 (25%) had abnormal serum orosomucoid values. Except for those with inflammatory diseases, only 26% of the infants of this group without documented infection had higher serum orosomucoid concentrationsthan those of the control group.
Among the 778 determinations when orosomucoid was increased, the increase was slight (only six values >1500 mg/L). Higher values were generally noted in the first and the second day of lifefollowing a complicated delivery; thereafter, orosomucoid concentration fell rapidly to normal values within the first postnatal week.
Orosomucoid vs Fibrinogen and 1gM Concentration
In the group of infants with bacterial infections, fibrinogen and 1gM concentrations were evaluated with orosomucoid in 58 and 49 cases of various bacterial infections, respectively. Fibrinogen was increased in 40 of the 58 cases (69%), whereas in the same series orosomucoid was higher than normal in 48 cases (83%). In 18 cases there was a discrepancy between changes in fibrinogen and orosomucoid concentrations: in 13, orosomucoid was increased and fibrinogen normal; in the other five, the opposite was true.
1gM concentrations were increased (7) in only 25 of the 49 cases (51%), whereas an orosomucoid increase occurred in 36 cases (73%). In two cases only serum 1gM was increased while serum orosomucoid was normal, but in 10 cases the opposite situation was observed.
Discussion
The need for a quick and safe guide to direct the diagnosis and treatment of infections is obvious in the neonatal period. In the present study, fibrinogen and 1gM determination are not comparable to orosomucoid in early detection of infection.
We found a larger number of false negatives with fibrinogen (31%) and 1gM (49%); detection of the increase of serum orosomucoid concentrations appears to be quicker and more sensitive. The frequency of hemolytic syndromes in the neonatal period is an obstacle for the use of haptoglobin. C-reactive protein seems interesting, and we are currently conducting a study to compare its utility with that of orosomucoid.
Our data show that the concentrations of orosomucoid were very low at birth in the control group of neonates, in comparison with normal adult values. Orosomucoid increased very rapidly during the first postnatal week: at day six, the concentrations were threefold greater than at day one; thereafter, the increase was much slower, adult values being reached by the age of ten months. Furthermore, in very-low-birthweight infants the normal values of orosomucoid observed at day one and two were lower than in full-term infants.
These results are in agreement with the observations that, despite the very low molecular mass of orosomucoid, there isno transfer of this protein from mother to fetus (16) , and synthesis of orosomucoid by the liver of the fetus occurs as early as 32 days of gestation (17) . Therefore, serum concentrations of orosomucoid in newborn infants must be interpreted according to newborn infants according to gestational and postnatal age. In the neonatal period, an increase of serum orosomucoid concentrations from causes other than infection occurred in only 26% of the cases studied. Furthermore, these increases were always slight and brief.
Serum orosomucoid determination was not very useful in viral and parasitological infections. Only 53% of these infants had increased orosomucoid values, and these were in cases of viral infections accompanied by inflammation.
On the other hand, a high orosomucoid concentration in combination with clinical symptoms is highly suggestive of bacterial infection, which still must be confirmed by bacteriological findings. However, one must be particularly aware of the postnatal variation of serum orosomucoid values when #{149} diagnosing bacterial infection. The capacity to synthesize orosomucoid occurs quite early, and the increase of orosomucoid, which can be as high as in adult inflammations, is a very sensitive parameter because normal values are very low (so orosomucoid values observed during infections can be 15-fold greater than normal values). The variation of these orosomucoid concentrations is of great interest in the monitoring of bacterial diseases; especially, it could help increase the efficiency of treatment. In our experience, it allowed us to reduce the time of antibiotherapy.
In the present investigation, 15% of false negatives were observed in severe bacterial infections: septicemia, meningitis, and peritonitis, which is quite similar to the findings of Sabel and Wadsworth (15) with regard to C-reactive protein. It is noteworthy that most of the cases with normal orosomucoid concentrations were infected with Streptococcus and that clinical evolution of these infants was not very satisfactory. Four infected infants with normal orosomucoid values died (an important one to note is the case of peritonitis with an orosomucoid concentration of 80 mg/L). These last data support the findings of Philip (18) , showing that orosomucoid appears to have a protective role in the ability to combat infections. Further studies are required to know whether these false-negative results have prognostic significance and whether the ability of the liver to synthetize a large quantity of orosomucoid is an indication of the capacity of newborn infants to fight infections.
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